Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness

Overview of attention for article published in Frontiers in Medicine, February 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

policy: 1 policy source
twitter: 5 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 16 Mendeley

Summary Policy documents X Wikipedia Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Overview of HTA Processes for Time-limited Recommendations

Cited by Canadian Agency for Drugs and Technologies in Health on 11 May 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.